MAIA Biotechnology, Inc. Banner Image

MAIA Biotechnology, Inc.

  • Ticker MAIA
    Exchange NYSE More
  • Industry Biotechnology More
  • Sector Healthcare More
MAIA Biotechnology, Inc. Logo Image
  • 1-10 Employees
  • Based in Chicago, Illinois
MAIA is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Their lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of NSCLCMore patients with telomerase-positive cancer cells.
5.0 / 5.0 (1)

MAIA Biotechnology, Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.

MAIA Biotechnology, Inc.

Most Recent Annual Report

MAIA Biotechnology, Inc.
MOST RECENT 2022 Annual Report and Form 10K
MAIA Biotechnology, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!